Mass Spec Confirmed Lyophilized RUO

GLP1-S

$120.00

GLP1-S, a GLP-1 receptor agonist, was initially developed for type 2 diabetes but is now widely used for significant, long-term fat loss. It mimics incretin hormones, slowing gastric emptying, suppressing appetite, and improving insulin sensitivity, which reduces calorie intake and boosts metabolic health. Clinical studies demonstrate it can achieve 15–20% body weight reduction, making it a highly effective option for obesity management. It also stabilizes blood sugar, curbs cravings, and promotes cardiovascular health, ideal for those with weight and metabolic issues.

Size

In stock

Account required · Research professionals only

Live Certificates of Analysis

Lot: RH-2026-001
Purity ≥99% HPLC
Identity Confirmed Mass Spec
Endotoxin <1 EU/mg LAL Test
DOWNLOAD COA

Research Application

GLP1-S (Semaglutide analog) is a selective GLP-1 receptor agonist engineered with a C18 fatty di-acid chain for extended half-life in metabolic receptor research.

Research Use Only. This compound is supplied strictly for in-vitro laboratory research by qualified professionals. Not for human or veterinary administration. By purchasing you confirm compliance with all applicable regulations.

Compound Specifications

Compound GLP1-S
Sequence [Aib8,Arg34]GLP-1(7-37)-Lys(AEEAc-AEEAc-γ-Glu-17-carboxyheptadecanoyl)
Molecular Formula C187H291N45O59
Molecular Weight 4113.64 g/mol
Purity ≥99% by HPLC
Identity Confirmed by Mass Spectrometry
Appearance White lyophilized powder

Done shopping?

Review your research compounds or proceed to checkout.

🔥 LIMITED TIME • BUY 2 GET 1 FREE
Buy 2 Get 1 FREE! Add 3 to cart
Use Code: 3for2